Ahead Of PCE Data Release, Here's What CME FedWatch Is Indicating About December Fed Rate Cut Chances

Published : Dec 05, 2025, 06:05 PM IST
https://stocktwits.com/news-articles/markets/equity/pce-data-fed-preferred-inflation-gauge-december-fed-rate-cut-chances/cLIS2suREkG

Synopsis

According to data from the CME FedWatch tool, there is an 87.2% probability of a 25 basis point rate cut next week.

The Federal Reserve’s preferred inflation gauge, the Personal Consumption Expenditures (PCE) index, is all set to be released later in the day, ahead of the Federal Open Market Committee’s (FOMC) meeting scheduled for next week.

According to a Dow Jones estimate cited by MarketWatch, September PCE is expected to rise 0.3% for the headline number, while the core PCE is expected to rise 0.2% for the period. On an annual basis, headline PCE is expected to be unchanged at 2.9% in September, while core inflation is likely to be at 2.8%.

What Are Fed Rate Cut Chances?

According to data from the CME FedWatch tool, there is a 87.2% probability of a 25-basis-point rate cut next week.

This comes amid signs of a cooling labor market. According to data released by payroll processing firm ADP, U.S. companies unexpectedly cut 32,000 jobs in November amid an uncertain macroeconomic environment.

Small businesses registered a sharp pullback during the month, with a net decline of 120,000 employees, while mid-sized and large businesses added 90,000 employees on a net basis.

Get updates to this story developing directly on Stocktwits.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Recommended Stories

Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious?
Elon Musk Says He’s ‘Vindicated’ After Court Revives His Controversial $140B Tesla Pay Package